Updates
February 2023
Medical Affairs Digest
1st February 2023 Edition
- Top ten observations from 2022 in life sciences digital and analytics
- Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions
- The next generation of evidence-based medicine
Medical Affairs Digest
2nd February 2023 Edition
- Do You Hear Me? When HCPs Want Their Opinions Heard
- How to effectively engage KOLs in a virtual format
- 4 Reasons Pharma’s Organizational Structures Are Not Built for Digital Transformation
January 2023
Medical Affairs Digest
1st January 2023 Edition
- The digital therapeutics revolution is happening and Big Pharma is buying in — with caution
- Resilience in life sciences: Emerging stronger from the downturn
- Trendspotting: Hybrid and Decentralized Clinical Trials, Patient-Centricity, and Increased Remote Patient Monitoring in 2023
Medical Affairs Digest
2nd January 2023 Edition
- What’s keeping pharma leaders up at night
- Revealing the true value of medical affairs
- The Digital Era is Expanding the Scope and Impact for Medical Affairs
October 2022
Medical Affairs Digest
October 2022 Edition
- Agents of change: How the Gen Z medical science liaison will transform healthcare
- How to run an interactive MSLs training in a virtual format for continued efficiency and excellence
- Reevaluating “Difficult” Doctor-Patient Relationships
December 2022
Medical Affairs Digest
December 2022 Edition
- The future of biotech: AI-driven drug discovery
- Medical affairs in a digital-first world: Benefits and challenges
- From insight to action in Medical Affairs
November 2022
Medical Affairs Digest
November 2022 1st Edition
- Emerging from disruption: The future of pharma operations strategy
- Digital Strategies For Optimizing Clinical Development
- The design and evaluation of hybrid controlled trials that leverage external data and randomization
Medical Affairs Digest
November 2022 2nd Edition
- How AI could revolutionize drug discovery
- The role of Medical Affairs in cutting CO2 emissions
- Driving the Evolution of Medical Affairs and MSLs
September 2022
Medical Affairs Digest
September 2022 1st Edition
- Patient involvement in clinical trials
- What Makes an Oncology Clinical Trial Site Stand Out from the Competition?
- When Will We Solve the Patient Engagement Dilemma?
Medical Affairs Digest
September 2022 2nd Edition
- Developing pharmaceutical launch leaders and company-wide capabilities at scale
- How to build a medical affairs go-to-market framework for the future
- How digital transformation is driving action in healthcare
July 2022
Medical Affairs Digest
July 2022 Edition
- Opinion: Many Clinical Trials Fail to Navigate the Literature
- Clinical trial trends and market changes to watch out for in 2022-23
- Myths about diversity in clinical trials reduce return on investment for industry
August 2022
Medical Affairs Digest
August 2022 Edition
- Developing pharmaceutical launch leadeanand company-wide capabilities at scale
- Achieving Effective KOL Engagement and Intelligence Gathering During Medical Conferences
- Evolving Trends: Continuing Medical Education (CME) In The Digital Space
May 2022
Medical Affairs Digest
May 2022 Edition
- Three challenges to global collaboration in pharma and how to overcome them
- Medical Affairs Teams need to Learn to Engage with Digital Opinion Leaders
- From the 2022 Medical Affairs Professional Society (MAPS) Global Annual Meeting
June 2022
Medical Affairs Digest
June 2022 Edition
- A look ahead: How medical affairs may evolve over the next five years
- Digital Opinion Leaders (DOLs): Who are they and how can Pharma engage them?
- How digital helps a life sciences leader move at light speed
April 2022
Medical Affairs Digest
April 2022 1st Edition
- Patient Influencers: The Next Frontier in Direct-to-Consumer Pharmaceutical Marketing
- Scientific Share of Voice as KPI for Medical Activities – Key Success Factors
- Medical Affairs Transformation in Specialty Pharma: Next-Level Collaboration at the Core
Medical Affairs Digest
April 2022 2nd Edition
- Decentralized Clinical Trials: A Revolution Improving Safety, Efficacy, and Speed
- International Clinical Trials: how the war in Ukraine affects the Clinical Trial market and patients and what kind of amendments to legislation might be needed in the future
- How can real-world evidence help medical affairs professionals?
March 2022
Medical Affairs Digest
March 2022 1st Edition
- Digital interactions with HCPs — moving from Webinars to a more interactive communication tool: a new normal for Pharma Industry
- What role for virtual engagement in 2022?
- Digital transformation in the pharma industry post-Covid
Medical Affairs Digest
March 2022 2nd Edition
- Clinical Trial Trens- what will 2022 bring?
- Prediction of treatment outcome in clinical trials under a personalized medicine perspective
- Clinical Data Management: Past, Present and Future
February 2022
Medical Affairs Digest
February 2022 1st Edition
- The Future of Clinical Trials is Here Today
- 11 clinical trials that will shape medicine in 2022
- Are you ready? EU’s Clinical Trials Regulation and portal goes live 31 January
Medical Affairs Digest
February 2022 2nd Edition
- Overcoming The Challenges of Outsourcing Rare Disease Trials
- EMA launches new centre to gather real-world health data for drug regulation
- How the Pandemic Shaped the Next Wave of Health Tech Innovation
December 2021
Medical Affairs Digest
December 2021
- Move over KOLs, there’s a new influencer in town. Meet the digital opinion leaders taking over online
- The impact of COVID-19 on cancer care and oncology clinical research: an experts’ perspective
- COVID Vaccine Trials Offer Lessons for Improving Clinical Trial Diversity
January 2022
Medical Affairs Digest
January 2022
- A new operating model for pharma: How the pandemic has influenced priorities
- Discovering the unique power of DOLs – are you harnessing the power of pharma’s new educators?
- Are You Leveraging KOLs For Biopharma Market Access As Much As You Could Be?
October 2021
Medical Affairs Digest
October 2021
- Medical Affairs Digitization
- Clinical Trial Trends: 18 Months of Faster Tech Adoption, Real World Data, Increased Collaboration
- How To Diversify Trials: Recruitment Protocols, Other Approaches
November 2021
Medical Affairs Digest
November 2021
- The New Hybrid KOL Engagement Model
- AI: Rewriting the Clinical Development Handbook
- Advances In Precision Medicine And Artificial Intelligence Are Set To Transform Cancer Treatment
September 2021
Medical Affairs Digest
September 2021 1st Edition
- Building Trust in Real-World Evidence
- Diversity & Inclusion in Clinical Trials: What Role Can Medical Affairs Play?
- The Time is Right to Disrupt Clinical Cancer Trials and Accelerate Innovation
Medical Affairs Digest
September 2021 2nd Edition
- Aspiration vs Actuality – Assessing the progress of digital excellence in Medical Affairs
- How Medical Affairs Can Contribute to Successful Drug Launch
- Getting strategic about new-product submissions in the pharma industry
July 2021
Medical Affairs Digest
July 2021 1st Edition
- No place like home? Stepping up the decentralization of clinical trials
- Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic
- Digital Technology-Based Telemedicine for the COVID-19 Pandemic
August 2021
Medical Affairs Digest
August 2021 1st Edition
- A Decade in Review: Changes in Temporal and Regional Interest in the Medical Science Liaison Role
- Medical Affairs – The Future Strategists Of The Pharma Industry?
- Virtual relationships with KOLs: Insights from the COVID-19 scenario
